Literature DB >> 15298344

Effect of maternal low-protein diet and taurine on the vulnerability of adult Wistar rat islets to cytokines.

S Merezak1, B Reusens, A Renard, K Goosse, L Kalbe, M T Ahn, J Tamarit-Rodriguez, C Remacle.   

Abstract

AIMS/HYPOTHESIS: A maternal low-protein diet has been shown to induce an increased susceptibility of fetal islets to cytokines, but this effect can be avoided by maternal taurine supplementation. Here, we question whether these effects persist until adulthood in the offspring, despite the animal having a normal diet after weaning.
METHODS: Pregnant Wistar rats received a diet of either 20% or 8% protein (control [C group] and recuperated [R group] respectively), which was or was not supplemented with taurine (control treated with taurine [CT group] and recuperated treated with taurine [RT group] respectively) during gestation and lactation. When the female offspring reached adulthood, an OGTT was performed. In a second stage, islets were isolated from these offspring, then pretreated or not with taurine, and subsequently treated with cytokines.
RESULTS: Fasting glycaemia was higher (p<0.05) and insulinaemia was lower (p<0.01) in the R group than in the C group. Taurine supplementation decreased insulinaemia in the CT group and tended to increase it in the RT group. After the OGTT, glycaemia in R animals was not different from that in the C group, despite a blunted insulin response (p<0.05) which was restored by taurine. Supplementation in C-group mothers led to a weak glucose intolerance. In vitro, more apoptotic cells were observed in R islets after cytokines treatment (p<0.01). The addition of taurine to the culture medium in the R and C groups protected the islets from the cytokines (p<0.01). Maternal taurine supplementation decreased the sensitivity of islets in the RT group (p<0.01), but increased sensitivity in the CT group (p<0.01). CONCLUSIONS/
INTERPRETATION: The increased vulnerability of islets to cytokines due to a restriction of protein during fetal development was still evident when the offspring reached adulthood. The low-protein diet also induced hyperglycaemia in the presence of lower insulinaemia. Taurine supplementation protected adult islets of the R group from cytokine toxicity and restored the insulinaemia. However, unnecessary supplementation of taurine could have detrimental effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15298344     DOI: 10.1007/s00125-004-1357-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

Review 1.  Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes?

Authors:  J D Trudeau; J P Dutz; E Arany; D J Hill; W E Fieldus; D T Finegood
Journal:  Diabetes       Date:  2000-01       Impact factor: 9.461

2.  Altered adipocyte properties in the offspring of protein malnourished rats.

Authors:  P R Shepherd; N J Crowther; M Desai; C N Hales; S E Ozanne
Journal:  Br J Nutr       Date:  1997-07       Impact factor: 3.718

Review 3.  The role of taurine in diabetes and the development of diabetic complications.

Authors:  S H Hansen
Journal:  Diabetes Metab Res Rev       Date:  2001 Sep-Oct       Impact factor: 4.876

Review 4.  Taurine in development.

Authors:  J A Sturman
Journal:  Physiol Rev       Date:  1993-01       Impact factor: 37.312

Review 5.  Nutritional influences on pancreatic development and potential links with non-insulin-dependent diabetes.

Authors:  S Dahri; B Reusens; C Remacle; J J Hoet
Journal:  Proc Nutr Soc       Date:  1995-07       Impact factor: 6.297

6.  Taurine chloramine inhibits inducible nitric oxide synthase and TNF-alpha gene expression in activated alveolar macrophages: decreased NF-kappaB activation and IkappaB kinase activity.

Authors:  M Barua; Y Liu; M R Quinn
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  Insulin-like growth factor I reverses interleukin-1beta inhibition of insulin secretion, induction of nitric oxide synthase and cytokine-mediated apoptosis in rat islets of Langerhans.

Authors:  J G Mabley; V Belin; N John; I C Green
Journal:  FEBS Lett       Date:  1997-11-10       Impact factor: 4.124

8.  A protein-restricted diet during pregnancy alters in vitro insulin secretion from islets of fetal Wistar rats.

Authors:  H Cherif; B Reusens; S Dahri; C Remacle
Journal:  J Nutr       Date:  2001-05       Impact factor: 4.798

9.  Intrauterine programming of fetal islet gene expression in rats--effects of maternal protein restriction during gestation revealed by proteome analysis.

Authors:  T Sparre; B Reusens; H Cherif; M R Larsen; P Roepstorff; S J Fey; P Mose Larsen; C Remacle; J Nerup
Journal:  Diabetologia       Date:  2003-09-12       Impact factor: 10.122

10.  Interleukin-1 beta-induced nitric oxide synthase expression by rat pancreatic beta-cells: evidence for the involvement of nuclear factor kappa B in the signaling mechanism.

Authors:  G Kwon; J A Corbett; C P Rodi; P Sullivan; M L McDaniel
Journal:  Endocrinology       Date:  1995-11       Impact factor: 4.736

View more
  20 in total

Review 1.  Developmental programming of the metabolic syndrome by maternal nutritional imbalance: how strong is the evidence from experimental models in mammals?

Authors:  James A Armitage; Imran Y Khan; Paul D Taylor; Peter W Nathanielsz; Lucilla Poston
Journal:  J Physiol       Date:  2004-09-30       Impact factor: 5.182

2.  Alteration of mitochondrial function in adult rat offspring of malnourished dams.

Authors:  Brigitte Reusens; Nicolas Theys; Claude Remacle
Journal:  World J Diabetes       Date:  2011-09-15

3.  Maternal taurine supplementation in the late pregnant rat stimulates postnatal growth and induces obesity and insulin resistance in adult offspring.

Authors:  Karin Hultman; Camilla Alexanderson; Louise Mannerås; Mats Sandberg; Agneta Holmäng; Thomas Jansson
Journal:  J Physiol       Date:  2007-01-04       Impact factor: 5.182

4.  Taurine supplement in early life altered islet morphology, decreased insulitis and delayed the onset of diabetes in non-obese diabetic mice.

Authors:  E Arany; B Strutt; P Romanus; C Remacle; B Reusens; D J Hill
Journal:  Diabetologia       Date:  2004-10-21       Impact factor: 10.122

5.  A maternal low protein diet has pronounced effects on mitochondrial gene expression in offspring liver and skeletal muscle; protective effect of taurine.

Authors:  Ole Hartvig Mortensen; Hanne Lodberg Olsen; Lis Frandsen; Peter Eigil Nielsen; Finn Cilius Nielsen; Niels Grunnet; Bjørn Quistorff
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

6.  Established diet-induced obesity in female rats leads to offspring hyperphagia, adiposity and insulin resistance.

Authors:  P Nivoit; C Morens; F A Van Assche; E Jansen; L Poston; C Remacle; B Reusens
Journal:  Diabetologia       Date:  2009-03-14       Impact factor: 10.122

Review 7.  Role of the hypothalamic-pituitary-adrenal axis in developmental programming of health and disease.

Authors:  Fuxia Xiong; Lubo Zhang
Journal:  Front Neuroendocrinol       Date:  2012-11-27       Impact factor: 8.606

8.  Different mechanisms operating during different critical time-windows reduce rat fetal beta cell mass due to a maternal low-protein or low-energy diet.

Authors:  O Dumortier; B Blondeau; B Duvillié; B Reusens; B Bréant; C Remacle
Journal:  Diabetologia       Date:  2007-09-19       Impact factor: 10.122

9.  Maternal dietary vitamin restriction increases body fat content but not insulin resistance in WNIN rat offspring up to 6 months of age.

Authors:  L Venu; N Harishankar; T Prasanna Krishna; M Raghunath
Journal:  Diabetologia       Date:  2004-09-10       Impact factor: 10.122

10.  Pregnancy Hyperglycemia in Prolactin Receptor Mutant, but Not Prolactin Mutant, Mice and Feeding-Responsive Regulation of Placental Lactogen Genes Implies Placental Control of Maternal Glucose Homeostasis.

Authors:  Saara M Rawn; Carol Huang; Martha Hughes; Rustem Shaykhutdinov; Hans J Vogel; James C Cross
Journal:  Biol Reprod       Date:  2015-08-12       Impact factor: 4.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.